Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer, Secondary cancers
Closed
Other
This study is measuring the level of a biomarker in the blood to work out early on if bevacizumab is working.
It is for women whose cancer has spread outside the pelvis or elsewhere in the body and who have:
ovarian cancer,
primary peritoneal cancer or
fallopian tube cancer
These cancers are treated in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.
Cancer Research UK supports this trial.
Recruitment start: 16 March 2021
Recruitment end: 31 January 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Jayson
Cancer Research UK
University of Manchester
This is Cancer Research UK trial number CRUK/19/015.
Last reviewed: 30 Jan 2026
CRUK internal database number: 17183
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
